Climb Bio, Inc. (NASDAQ:CLYM) Receives Average Recommendation of "Buy" from Brokerages
Shares of Climb Bio, Inc. (NASDAQ:CLYM - Get Free Report) have been assigned an average recommendation of "Buy" from the twelve analysts that are currently covering the stock, Marketbeat reports. One...